BDSX Stock Analysis: Buy, Sell, or Hold?
BDSX - Biodesix, Inc. Common Stock
$21.42
-0.73 (-3.30%)
▼
5d:
-2.59%
30d:
+39.45%
90d:
+60.81%
BUY
MODERATE Confidence
Analysis Updated: Jul 10, 2026 12:00 AM ET
Earnings: Aug 06, 2026
23d
Get Alerted When BDSX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: BDSX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: BDSX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: BDSX is currently trading at $21.42, which is considered slightly high relative to its 30-day fair value range of $15.45 to $21.95.
Technical Outlook: Technically, BDSX is in a strong uptrend. Immediate support is located at $18.91, while resistance sits at $24.92. Short-term momentum is weak, with the stock down 3.3% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $30.83 (+43.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, BDSX is in a strong uptrend. Immediate support is located at $18.91, while resistance sits at $24.92. Short-term momentum is weak, with the stock down 3.3% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $30.83 (+43.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$15.45 -
$21.95
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
61.6%
All Signals
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.3%)
- BULLISH: Trading 43.9% below Wall St target ($30.83)
Trading Range Analysis
30-Day Trading Range
$15.45 -
$21.95
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$18.91
Resistance Level
$24.92
Current Trend
Strong Uptrend
Technical data as of
Jul 10, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-12.13
Wall Street Target
$30.83
(+43.9%)
Revenue Growth (YoY)
42.3%
Profit Margin
-33.3%
Share & Embed Analysis
Last updated: July 13, 2026 3:23 AM ET
Data refreshes hourly during market hours. Next update: 4:23 AM
Data refreshes hourly during market hours. Next update: 4:23 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BDSX showing a specific setup today?
Insider Activity (6 Months)
3
Buys
15
Sells
Net
INSIDERS SELLING
Recent Transactions
Gary Anthony Pestano
SELL
556 shares
2026-02-23
Kieran O'kane
SELL
535 shares
2026-02-23
Robin Harper Cowie
SELL
535 shares
2026-02-23
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$591 | 65 BUY |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$242 | 62 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$157 | 63 BUY |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$271 | 59 HOLD |
